upvote
https://pubmed.ncbi.nlm.nih.gov/35012793/

I’m sure someone will find some reason to dismiss or excuse these deaths, as anyone who brings up the negatives of psychedelics is usually shouted down on this site.

The cardiotoxic effects of ibogaine are well known, though. This is why analogs without the cardiotoxic effect are an active area of study.

Of all of the incredible claims about ibogaine in this thread it’s sad that the only one where sources are being demanded is for the high risk of death, which even among ibogaine communities is well known.

reply
To give context to this, the person didn't post a study in which anyone died, instead a study that claims 2 people have died in 2 separate studies. Despite this claim, it actually only references one of these studies, the second one is never referenced.

If you look at, at the one referenced study, there was a coronial inquiry and an investigation by New Zealand's Health and Disability Commissioner that found the doctor who was supervising was in breach of their duty of care.

Yes, there can and have been negative side effects for MANY drugs, but blaming the drug, when a government body has investigated the incident placed the blame elsewhere is an outrageous bad faith claim.

Additionally, that study was for Opioid addiction, and a person also died before even getting into the study (so, iBogain is probably the lesser of two evils).

As for the snarky comment about people finding excuses on this site, no, people actually just read citations on this site, instead of just trust me bro. When your citation claims a doctor is responsible, but you say it was the drug, do you see how one can only assume you are disingenuous?

The full Journal is here: https://www.tandfonline.com/doi/full/10.1080/00952990.2017.1...

Here is a relevant extract:

> A third patient of Provider 1 died during treatment before they were formally enrolled. Of 13 participants enrolled through Provider 2, one voluntarily left the study at eight months and a second was lost to follow up at 11 months post-treatment. The fatality was the subject of two investigations, a coronial inquiry and the second involving New Zealand’s Health and Disability Commissioner (HDC). The latter, completed first, described the treatment provider as being in breach of their duty of care but did not offer a medical explanation for the death.

reply